PLOP
US20210151206A1
THE INVINCIBLE TEAM
Thanks as always. That one patent application resulting from the TG funded effort, IMO, had the best chance to slip by the USPTO examiner and be approved. It was the only solid lead reported in the Nature paper that I recall.
Sadly it was rejected. And in no unambiguous terms, as the examiner used quite strong wording IMO in his very long rebuttal. He even went so far as to call LENR (which the team denied it being) "fringe science", and gasp, used Schenkel's own public writings against him. What a low blow.
Nothing new here, LENR has seen this all before. As always it appears that whoever wants to capitalize/monetize on their lab results, or theory, will just have to make something with it, and go from there.